Literature DB >> 22222465

In vitro biocompatibility of thermally gelling liquid mucoadhesive loaded curcuminoids in colorectal cancer chemoprevention.

Ming-Jenn Chen1, Ya-Min Cheng, Pei-Heng Lai, June-Fu Wu, Yi-Chiang Hsu.   

Abstract

PURPOSE: Colorectal cancer (CRC) is the third leading cause of cancer death in Taiwan; it ranks top three in the cancer mortality rate. Curcuminoids are derived from the rhizome of Curcuma longa. It has shown anti-cancer activity and apoptosis induction in a variety of cancer cell lines. This aims to study the potential of Poloxamer 407 as the thermogelling and mucoadhesive polymer for development of a site-targeting delivery system to enhance the localized delivery of curcuminoids to the colorectal cells for CRC chemotherapy.
METHODS: The mucoadhesive strength and rheological properties were measured as a function of poloxamer loaded with curcuminoids.
RESULTS: The gelation temperature of Poloxamer 407 was found to vary with its concentration and start gelling at 37°C at the concentration of 15.5% (w/v). To ensure gelation at physiological temperature after intra-rectal application, gelation temperature was determined by rheological measurement as well as by its physical appearance. The results indicated that its mucoadhesive strength also shows a dependency on temperature, which appears to be related to the increment in the maximum strength and average strength of the polymer.
CONCLUSION: The results have suggested that Poloxamer 407 could be a potential thermogelling and mucoadhesive polymer for the development of a site-targeting colorectal drug delivery system for curcuminoids in colorectal cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222465     DOI: 10.1007/s00384-011-1393-3

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  24 in total

1.  Physicochemical characterization and in vivo evaluation of poloxamer-based solid suppository containing diclofenac sodium in rats.

Authors:  Chul Soon Yong; Yu-Kyoung Oh; Yong-Il Kim; Jong Oh Kim; Bong-Kyu Yoo; Jong-Dal Rhee; Kang Choon Lee; Dae-Duk Kim; Young-Joon Park; Chong-Kook Kim; Han-Gon Choi
Journal:  Int J Pharm       Date:  2005-09-14       Impact factor: 5.875

2.  Thermally reversible in situ gelling carbamazepine liquid suppository.

Authors:  Amal El-Kamel; Mona El-Khatib
Journal:  Drug Deliv       Date:  2006 Mar-Apr       Impact factor: 6.419

Review 3.  Cancer risk and diet in India.

Authors:  R Sinha; D E Anderson; S S McDonald; P Greenwald
Journal:  J Postgrad Med       Date:  2003 Jul-Sep       Impact factor: 1.476

4.  Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo.

Authors:  Hiroyuki Shibata; Hiroyuki Yamakoshi; Atsuko Sato; Hisatsugu Ohori; Yuichi Kakudo; Chieko Kudo; Yayoi Takahashi; Mika Watanabe; Hiroshi Takano; Chikashi Ishioka; Tetsuo Noda; Yoshiharu Iwabuchi
Journal:  Cancer Sci       Date:  2009-05       Impact factor: 6.716

5.  Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.

Authors:  W Chearwae; S Anuchapreeda; K Nandigama; S V Ambudkar; P Limtrakul
Journal:  Biochem Pharmacol       Date:  2004-11-15       Impact factor: 5.858

6.  Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.

Authors:  Svetlana Gelperina; Olga Maksimenko; Alexander Khalansky; Lyudmila Vanchugova; Elena Shipulo; Kenul Abbasova; Rustam Berdiev; Stefanie Wohlfart; Nina Chepurnova; Jörg Kreuter
Journal:  Eur J Pharm Biopharm       Date:  2009-09-13       Impact factor: 5.571

7.  Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease.

Authors:  Vivek Ramshankar Yadav; Sarasija Suresh; Kshama Devi; Seema Yadav
Journal:  J Pharm Pharmacol       Date:  2009-03       Impact factor: 3.765

8.  Curcuminoids suppress the growth of pharynx and nasopharyngeal carcinoma cells through induced apoptosis.

Authors:  Yo-Tsai Lin; Leng-Fang Wang; Yi-Chiang Hsu
Journal:  J Agric Food Chem       Date:  2009-05-13       Impact factor: 5.279

9.  In vitro drug liberation and kinetics of sustained release indomethacin suppository.

Authors:  Gülçin Uzunkaya; Nazan Bergişadi
Journal:  Farmaco       Date:  2003-07

10.  Comparison of self-microemulsifying drug delivery system versus solid dispersion technology used in the improvement of dissolution rate and bioavailability of vinpocetine.

Authors:  Ying Chen; Gao Li; Jian-Geng Huang; Rui-Hua Wang; Hong Liu; Ren Tang
Journal:  Yao Xue Xue Bao       Date:  2009-06
View more
  11 in total

1.  Docetaxel-loaded thermosensitive and bioadhesive nanomicelles as a rectal drug delivery system for enhanced chemotherapeutic effect.

Authors:  Youn Gee Seo; Dong-Wuk Kim; Woo Hyun Yeo; Thiruganesh Ramasamy; Yu-Kyoung Oh; Young-Joon Park; Jung-Ae Kim; Dong Hoon Oh; Sae Kwang Ku; Jin Ki Kim; Chul Soon Yong; Jong Oh Kim; Han-Gon Choi
Journal:  Pharm Res       Date:  2013-04-03       Impact factor: 4.200

2.  pH dependent poly[2-(methacryloyloxyethyl)trimetylammonium chloride-co-methacrylic acid]hydrogels for enhanced targeted delivery of 5-fluorouracil in colon cancer cells.

Authors:  R K Mishra; K Ramasamy; N A Ahmad; Z Eshak; A B A Majeed
Journal:  J Mater Sci Mater Med       Date:  2014-01-08       Impact factor: 3.896

Review 3.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

4.  Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration.

Authors:  Fakhar Ud Din; Ju Yeon Choi; Dong Wuk Kim; Omer Mustapha; Dong Shik Kim; Raj Kumar Thapa; Sae Kwang Ku; Yu Seok Youn; Kyung Taek Oh; Chul Soon Yong; Jong Oh Kim; Han-Gon Choi
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Bisdemethoxycurcumin attenuates gastric adenocarcinoma growth by inducing mitochondrial dysfunction.

Authors:  Changjiang Luo; Zhixing DU; Xing Wei; Gang Chen; Zhongxue Fu
Journal:  Oncol Lett       Date:  2014-11-07       Impact factor: 2.967

6.  Curcuminoids from Curcuma longaL. reduced intestinal mucositis induced by 5-fluorouracil in mice: Bioadhesive, proliferative, anti-inflammatory and antioxidant effects.

Authors:  Edvande Xavier Dos Santos Filho; Paulo Henrique Marcelino Ávila; Carla Caroline Cunha Bastos; Aline Carvalho Batista; Letícia Nasser Naves; Ricardo Neves Marreto; Eliana Martins Lima; Elismauro Frascisco Mendonça; Marize Campos Valadares
Journal:  Toxicol Rep       Date:  2015-10-23

Review 7.  Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview.

Authors:  Elena Giuliano; Donatella Paolino; Massimo Fresta; Donato Cosco
Journal:  Pharmaceutics       Date:  2018-09-12       Impact factor: 6.321

Review 8.  Biochemistry, Safety, Pharmacological Activities, and Clinical Applications of Turmeric: A Mechanistic Review.

Authors:  Rabia Shabir Ahmad; Muhammad Bilal Hussain; Muhammad Tauseef Sultan; Muhammad Sajid Arshad; Marwa Waheed; Mohammad Ali Shariati; Sergey Plygun; Mohammad Hashem Hashempur
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-10       Impact factor: 2.629

9.  Development of in situ gelling and bio adhesive 5-Fluorouracil enema.

Authors:  Lu-Lu Wang; Wen-Sheng Zheng; Shao-Hua Chen; Xia-Qin Fang
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  In situ delivery of thermosensitive gel-mediated 5-fluorouracil microemulsion for the treatment of colorectal cancer.

Authors:  Lu-Lu Wang; Shuai Huang; Hui-Hui Guo; Yan-Xing Han; Wen-Sheng Zheng; Jian-Dong Jiang
Journal:  Drug Des Devel Ther       Date:  2016-09-08       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.